F6Z-95235-62913
2 vaccinations
5 coded responses
16 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 891 / NV
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Dose 1 — Moderna
-
2021-03-01
Registered in v-safe
-
2021-03-01
Dose 2 — Moderna
-
2021-03-01
Survey response — day 0, dose 2MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessFree text: Metallic taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Muscle or body achesAdult check-in
- 2021-03-07
-
2021-03-10
Health check-in — day 7, dose 2Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-15
Survey response — day 14, dose 2MedDRA: Pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: Body aches start in late afternoon, not like fever aches, more like just a sore bodyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
-
2021-03-29
Survey response — day 28, dose 2MedDRA: Arthralgia, Fatigue, Feeling abnormal, Myalgia — Feeling: FairFree text: Muscles and joints still sore second half of every day and very tired sometimes, not normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-05
- 2021-04-12
- 2021-06-01
-
2021-08-30
Survey response — 6 months, dose 2MedDRA: Fatigue, Muscular weakness, Pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chronic pain, muscle weakness in left shoulder (injection site); chronic fatigueMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-03-03
Survey response — 12 months, dose 2MedDRA: Office visit, Photophobia, Unevaluable event, Vision blurred, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: My vision has deteriorated rapidly, black spots, separations, extreme sensitivity, unable to focus · Healthcare visit (other): In person visits with opthamologist, still under care, nothing they can doMedDRA releases: 2024-11 · check-in free text available
-
2022-03-03
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-03-07
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Moderna | |
| 2 | 2021-03-01 | Moderna |
Call center
1 call center case
1 successful
Free text
Release 4 — day 0, dose 2
Systemic reaction (other): Metallic taste in mouth
Release 5 — day 14, dose 2
Symptoms: Body aches start in late afternoon, not like fever aches, more like just a sore body
Release 6 — day 28, dose 2
Symptoms: Muscles and joints still sore second half of every day and very tired sometimes, not normal
Release 9 — 6 months, dose 2
Symptoms: Chronic pain, muscle weakness in left shoulder (injection site); chronic fatigue
Release 11 — 12 months, dose 2
Symptoms: My vision has deteriorated rapidly, black spots, separations, extreme sensitivity, unable to focus
Healthcare visit (other): In person visits with opthamologist, still under care, nothing they can do
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Photophobia | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release